QTORIN
Live / Applied — Fourth extension granted (statement of use) (as of 19 Sept 2025)
What this means for you
Not registered yet, but its 26 Aug 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97567266
- Mark type
- Stylized text
- Filed
- 26 Aug 2022
- Published for opposition
- 25 Jul 2023
- Attorney of record
- Michael A. Geller
Goods and services
- Class 005 — Pharmaceuticals: Chemical drug delivery agent in the form of a semi-solid dissolvable medical gel that facilitates the delivery of rapamycin and macrolides of similar chemical structure acting on mammalian targets of rapamycin, by enabling and facilitating the placement of agents that act on mammalians for the delivery of rapamycin and macrolides of similar chemical structure in and on the skin
- Class 039 — Transportation and storage services: Delivery of goods, namely, delivery of chemical delivery systems for a medical topical gel application
Owner
- Palvella Therapeutics, Inc., Wayne, PA, US
- Palvella Therapeutics, Inc., Wayne, PA, US
Prosecution history
- 06 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Sept 2025 — SOU EXTENSION 4 GRANTED
- 19 Sept 2025 — SOU EXTENSION 4 FILED
- 19 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2025 — SOU EXTENSION 3 GRANTED
- 17 Mar 2025 — SOU EXTENSION 3 FILED
- 17 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2024 — SOU EXTENSION 2 GRANTED
- 16 Sept 2024 — SOU EXTENSION 2 FILED
- 16 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2024 — SOU EXTENSION 1 GRANTED